Lipid metabolism: A role for iron?

Current Opinion in Lipidology

Volumn 23, Issue 3, 2012, Pages 258-259

  Wlazlo, Nick ^a,b,c   Van Greevenbroek, Marleen M J ^b,c  

^a CATHARINA HOSPITAL   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; LIPID; TRIACYLGLYCEROL;

DISEASE ASSOCIATION; DYSLIPIDEMIA; FATTY LIVER; FERRITIN BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; IRON METABOLISM; IRON STORAGE; LIPID METABOLISM; METABOLIC SYNDROME X; NOTE; PRIORITY JOURNAL;

HUMANS; IRON; LIPID METABOLISM; METABOLIC DISEASES;

EID: 84861089383     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e328354752d     Document Type: Note

References (13)

1. Jiang R, Manson JE, MeigsJB, etal. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. J Am Med Assoc 2004; 291:711-717. (Pubitemid 38543791)
2. Lee BK, Kim Y, Kim YI. Association of serum ferritin with metabolic syndrome and diabetes mellitus in the South Korean general population according to the Korean National Health and Nutrition Examination Survey 2008. Metabolism 2011; 60:1416-1424.
3. Kim CH, Kim HK, Bae SJ, et al. Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women. Metabolism 2011; 60:414-420.
4. Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 2004; 27:2422-2428. (Pubitemid 39281396)
5. Vari IS, Balkau B, Kettaneh A, etal. Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2007; 30:1795-1801. (Pubitemid 47036354)
6. Mateo-Gallego R, Calmarza P, Jarauta E, et al. Serum ferritin is a major determinant of lipid phenotype in familial combined hyperlipidemiaand familial hypertriglyceridemia. Metabolism 2010; 59:154-158.
7. Aigner E, Hinz C, Steiner K, et al. Iron stores, liver transaminase levels and metabolic risk in healthy teenagers. Eur J Clin Invest 2010; 40:155-163.
8. Malmstrom R, Packard CJ, Caslake M, etal. Defective regulation of triglycer-ide metabolism by insulin in the liver in NIDDM. Diabetologia 1997; 40:454-462. (Pubitemid 27132616)
9. Fabbrini E, Magkos F, Mohammed BS, etal. Intrahepaticfat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 2009; 106:15430-15435.
10. Haap M, Machann J,von Friedeburg C, etal. Insulin sensitivity and liver fat: role of iron load. J Clin Endocrinol Metab 2011; 96:E958-E961.
11. Cooksey RC, Jones D, Gabrielsen S, et al. Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. Am J Physiol Endocrinol Metab 2010; 298:E1236-E1243.
12. Casanova-Esteban P, Guiral N, Andres E, et al. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis. Metabolism 2011; 60:830-834.
13. Valenti L, Moscatiello S, Vanni E, etal. Venesection for nonalcoholic fatty liver disease unresponsive to lifestyle counselling: a propensity score-adjusted observational study. QJM 2011; 104:141-149.